Takeda Pharmaceutical (TAK) Long-Term Investments: 2018-2025

Historic Long-Term Investments for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $2.3 billion.

  • Takeda Pharmaceutical's Long-Term Investments rose 0.09% to $2.3 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $2.3 billion, marking a year-over-year increase of 0.09%. This contributed to the annual value of $2.3 billion for FY2025, which is 2.45% down from last year.
  • Takeda Pharmaceutical's Long-Term Investments amounted to $2.3 billion in FY2025, which was down 2.45% from $2.4 billion recorded in FY2024.
  • In the past 5 years, Takeda Pharmaceutical's Long-Term Investments ranged from a high of $2.4 billion in FY2024 and a low of $2.1 billion during FY2023.
  • Its 3-year average for Long-Term Investments is $2.2 billion, with a median of $2.3 billion in 2025.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Long-Term Investments dropped by 7.73% in 2021, and later rose by 14.14% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Long-Term Investments (MRY) stood at $2.2 billion in 2021, then decreased by 6.51% to $2.1 billion in 2022, then dropped by 0.48% to $2.1 billion in 2023, then increased by 14.14% to $2.4 billion in 2024, then decreased by 2.45% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in FY2025, $2.4 billion for FY2024, and $2.1 billion during FY2023.